Radiation Therapy and Durvalumab With or Without Tremelimumab in Treating Participants With Unresectable, Locally Advanced, or Metastatic Bladder Cancer
Clinical trial NCT03601455 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03601455
- Sponsor
- Jonsson Comprehensive Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-26
- Primary completion
- 2027-01-31
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.